Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow launch of its respiratory syncytial virus (RSV) ...

China's crude oil imports fell 1.9% in 2024, data showed on Monday, the first annual decline in two decades outside of ...

The anticlimactic grand jury report managed to uncannily parrot the DeSantis administration's sometimes tortured views about ...

Five years after the COVID-19 pandemic hit South Carolina and the U.S., it is still changing health care, from wastewater ...

Pharmaceutical manufacturer LNK International, Inc., made the recall “out of an abundance of caution” when it was discovered ...

Vaishnaw wrote, “As the world’s largest democracy, India conducted the 2024 elections with over 640 million voters. The ...

The CDC is reporting a surge in emergency room visits for respiratory illnesses, including influenza, RSV, and COVID-19, with ...

Moderna laid out sales expectations for the coming year on Monday that were below even the much-diminished Wall Street ...

In pending ERC litigation, the government made a surprising concession regarding its interpretation of the partial suspension ...

Despite corporate leaders deploying RTO mandates, groundbreaking research on remote jobs, plus expert opinions underscore ...

Moderna ( MRNA) shares sank 23% at the open on Monday after the biotech giant lowered its 2025 sales forecast by $1 billion ...

In a post on X, Vaishnaw stated that Zuckerberg's statement about incumbent governments losing post-Covid, including India, ...